Prevention and Treatment of Common Hyperglycemia in Surgery

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

April 1, 2026

Conditions
SurgeryNon Diabetic Hyperglycemia
Interventions
DRUG

glucose, insulin, and potassium (GIK)

"GIK formulation: 100 g/L glucose, 33 U/L insulin, and 40 mmol/L KCl~Reference PMID: 32151220. Formulation represents a 50% reduction in compounded solute combination from the reference study, which allows for administration via peripheral IV."

DRUG

Crystalloid Infusion

placebo

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER